Injecting Drug Users (IDUs) are at a high risk of infection with blood-borne viruses including HIV, hepatitis B, and hepatitis C, and they are increasingly being targeted by policies that aim at preventing the spread of HIV. Approximately 10% of HIV infections worldwide are transmitted via injecting drug use. Many countries in Asia, including Thailand, Myanmar, Indonesia, Bangladesh, Nepal and India, have reported serious HIV epidemics among IDUs. Injecting drug use is an efficient and prevalent mode of HIV transmission, and it is the principal mode of transmission in some parts of the world. In the United States, approximately 10,000 IDUs are believed to acquire HIV each year, and they account for 8% of new HIV infections and 16% of people currently living with HIV (CDC Report, 2012). Increasing the number of HIV-infected IDUs who undergo diagnosis, increasing their access to care and prevention services, and increasing their adherence to a therapeutic regimen are the current challenges in tackling the HIV epidemic in this population. To overcome these obstacles, clinicians must have both the technical knowledge and skill required for assisting patients. The timeliness of HIV diagnosis and the initiation of antiretroviral treatment are major determinants of survival for HIV-infected people. IDUs are less likely than non-users in other transmission categories to seek early HIV counselling, testing and treatment. To improve the survival of IDUs, HIV prevention efforts must ensure early access to HIV testing and care, as well as encourage adherence to antiretroviral treatment to slow disease progression. Wafa Fageeh, Prevalence and Awareness of Sexually Transmitted Infections among Inmates of a Drug Rehabilitation Center in Saudi Arabia: A Cross-Sectional Study.
The impact factor of journal provides quantitative assessment tool for grading, evaluating, sorting and comparing journals of similar kind. It reflects the average number of citations to recent articles published in science and social science journals in a particular year or period, and is frequently used as a proxy for the relative importance of a journal within its field. It is first devised by Eugene Garfield, the founder of the Institute for Scientific Information. The impact factor of a journal is evaluated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Last date updated on May, 2021